Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G207 in Recurrent Malignant Glioma
NCT00028158Phase 2Completed
- Sponsor
- Medigene AG
- Start
- Dec 2001
- Modality
- Oncolytic Viruses
01
Overview
A Phase 2 trial of G207 in malignant glioma, sponsored by Medigene AG. Started Dec 2001; status: completed.
02
Drugs
G207
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00028158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028158.